Works matching IS 0741238X AND DT 2015 AND VI 32 AND IP 3
Results: 8
Efficacy and safety of linagliptin co-administered with low-dose metformin once daily versus high-dose metformin twice daily in treatment-naïve patients with type 2 diabetes: a double-blind randomized trial.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Cost-Effectiveness of the 21-Gene Breast Cancer Assay in Mexico.
- Published in:
- Advances in Therapy, 2015, v. 32, n. 3, p. 239, doi. 10.1007/s12325-015-0190-8
- By:
- Publication type:
- Article
Clinical Pharmacokinetics of the Anti-Interleukin-20 Monoclonal Antibody NNC0109-0012 in Healthy Volunteers and Patients with Psoriasis or Rheumatoid Arthritis.
- Published in:
- Advances in Therapy, 2015, v. 32, n. 3, p. 228, doi. 10.1007/s12325-015-0191-7
- By:
- Publication type:
- Article
Cost-Effectiveness Analysis of Mometasone Furoate Versus Beclomethasone Dipropionate for the Treatment of Pediatric Allergic Rhinitis in Colombia.
- Published in:
- Advances in Therapy, 2015, v. 32, n. 3, p. 254, doi. 10.1007/s12325-015-0192-6
- By:
- Publication type:
- Article
Nomenclature and Traceability Debate for Biosimilars: Small-Molecule Surrogates Lend Support for Distinguishable Nonproprietary Names.
- Published in:
- Advances in Therapy, 2015, v. 32, n. 3, p. 270, doi. 10.1007/s12325-015-0193-5
- By:
- Publication type:
- Article
Echinacea Reduces the Risk of Recurrent Respiratory Tract Infections and Complications: A Meta-Analysis of Randomized Controlled Trials.
- Published in:
- Advances in Therapy, 2015, v. 32, n. 3, p. 187, doi. 10.1007/s12325-015-0194-4
- By:
- Publication type:
- Article
Efficacy and Safety of Linagliptin Co-Administered with Low-Dose Metformin Once Daily Versus High-Dose Metformin Twice Daily in Treatment-Naïve Patients with Type 2 Diabetes: a Double-Blind Randomized Trial.
- Published in:
- Advances in Therapy, 2015, v. 32, n. 3, p. 201, doi. 10.1007/s12325-015-0195-3
- By:
- Publication type:
- Article
Effect of Rivaroxaban Versus Warfarin on Health Care Costs Among Nonvalvular Atrial Fibrillation Patients: Observations from Rivaroxaban Users and Matched Warfarin Users.
- Published in:
- Advances in Therapy, 2015, v. 32, n. 3, p. 216, doi. 10.1007/s12325-015-0189-1
- By:
- Publication type:
- Article